Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings

Transfusion

Volumn 53, Issue 3, 2013, Pages 505-517

  O'Connell, Robert J ^a   Gates, Robert G ^b   Bautista, Christian T ^b   Imbach, Michelle ^b   Eggleston, John C ^b   Beardsley, Stephen G ^b   Manak, Mark M ^b   Gonzales, Richard ^b   Rentas, Francisco J ^b   MacDonald, Victor W ^b   Cardo, Lisa J ^b   Reiber, David T ^b   Stramer, Susan L ^b   Michael, Nelson L ^b   Peel, Sheila A ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Army Medical Department Center and School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRYOPRESERVATION; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY WARD; GOLD STANDARD; HEPATITIS C RAPID TEST; HUMAN; INFECTION RISK; LABORATORY TEST; POSTTRANSFUSION HEPATITIS; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; THERMOSTABILITY;

ALGORITHMS; BLOOD DONORS; BLOOD PRESERVATION; BLOOD SAFETY; CLINICAL LABORATORY TECHNIQUES; DONOR SELECTION; EFFICIENCY; EMERGENCY MEDICAL SERVICES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84874945818     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03770.x     Document Type: Article

References (39)

1. Zou S, Musavi F, Notari EP, Stramer SL, Dodd RY,. Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008. Transfusion 2010; 50: 1487-94.
2. Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F,. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007; 47: 2338-47.
3. Bihl F, Castelli D, Marincola F, Dodd RY, Brander C,. Transfusion-transmitted infections. J Transl Med 2007; 5: 25.
4. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, Fang CT, Dodd RY,. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009; 49: 1609-20.
5. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL,. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50: 1495-504.
6. Kuliya-Gwarzo A,. Screening for blood transfusion transmissible viruses in resource limited settings. Internet J Infect Dis 2011; 9.
7. Shankar A, Akulwar AV, Singh Y, Sirohi YS, Chari VR,. Blood transfusion practices in military medicine. Med J Armed Forces India 2009; 65: 30-2.
8. Beekley AC,. Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. Crit Care Med 2008; 36 Suppl: S267-74.
9. Blackbourne LH,. Combat damage control surgery. Crit Care Med 2008; 36 Suppl: S304-10.
10. Perkins JG, Cap AP, Weiss BM, Reid TJ, Bolan CD,. Massive transfusion and nonsurgical hemostatic agents. Crit Care Med 2008; 36 Suppl: S325-39.
11. Kauvar DS, Holcomb JB, Norris GC, Hess JR,. Fresh whole blood transfusion: a controversial military practice. J Trauma 2006; 61: 181-4.
12. Burris DG, et al., editor. Emergency war surgery. Washington (DC): Borden Institute; 2004.
13. Eastridge BJ, Jenkins D, Flaherty S, Schiller H, Holcomb JB,. Trauma system development in a theater of war: experiences from Operation Iraqi Freedom and Operation Enduring Freedom. J Trauma 2006; 61: 1366-72; discussion 1372-3.
14. Spinella PC,. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med 2008; 36 Suppl: S340-5.
15. Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Azarow K, Holcomb JB,; 31st Combat Support Hospital Research Working Group. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med 2007; 35: 2576-81.
16. Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Azarow K, Holcomb JB,; 31st CSH Research Working Group. Fresh whole blood transfusions in coalition military, foreign national, and enemy combatant patients during Operation Iraqi Freedom at a U.S. combat support hospital. World J Surg 2008; 32: 2-6.
17. Hyams KC, Riddle J, Rubertone M, Trump D, Alter MJ, Cruess DF, Han X, Nainam OV, Seeff LB, Mazzuchi JF, Bailey S,. Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troops. Am J Epidemiol 2001; 153: 764-70.
18. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ,. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-14.
19. Hakre S, Peel SA, O'Connell RJ, Sanders-Buell EE, Jagodzinski LL, Eggleston JC, Myles O, Waterman PE, McBride RH, Eader SA, Davis KW, Rentas FJ, Sateren WB, Naito NA, Tobler SK, Tovanabutra S, Petruccelli BP, McCutchan FE, Michael NL, Cersovsky SB, Scott PT,. Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi Freedom. Transfusion 2011; 51: 473-85.
20. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G,. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-500.
21. Tong MJ, el-Farra NS, Reikes AR, Co RL,. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-6.
22. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD,. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012; 156: 271-8.
23. Dienstag JL, McHutchison JG,. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006; 130: 231-64. quiz 214-7.
24. Alter HJ, Houghton M,. Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med 2000; 6: 1082-6.
25. Owusu-Ofori S, Temple J, Sarkodie F, Candotti D, Allain JP,. Predonation testing of potential blood donors in resource-restricted settings. Transfusion 2005; 45: 1542-3.
26. Field SP, Allain JP,. Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol 2007; 60: 1073-5.
27. Clark KA, Kataaha P, Mwangi J, Nyamongo J,. Predonation testing of potential blood donors in resource-restricted settings. Transfusion 2005; 45: 130-2.
28. Strader DB, Wright T, Thomas DL, Seeff LB,; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147-71.
29. Macdonald VW, Flaherty SF, Ketchum LH,. Ambient temperature exposure of medical supplies in military deployments. Transfusion 2006; 46: 78A-9A.
30. Lachenbruch PA, Lynch CJ,. Assessing screening tests: extensions of McNemar's test. Stat Med 1998; 17: 2207-17.
31. Albritton WL, Vittinghoff E, Padian NS,. Human immunodeficiency virus testing for patient-based and population-based diagnosis. J Infect Dis 1996; 174 Suppl 2: S176-81.
32. Deeks JJ,. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. [See comment.] BMJ 2001; 323: 157-62.
33. Jaeschke R, Guyatt GH, Sackett DL,. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271: 703-7.
34. OraSure Technologies. OraQuick HCV rapid antibody test [package insert]. Bethlehem (PA): OraSure Technologies; 2010.
35. Lee SR, Kardos KW, Schiff E, Berne CA, Mounzer K, Banks AT, Tatum HA, Friel TJ, Demicco MP, Lee WM, Eder SE, Monto A, Yearwood GD, Guillon GB, Kurtz LA, Fischl M, Unangst JL, Kriebel L, Feiss G, Roehler M,. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. J Virol Methods 2011; 172: 27-31.
36. Vercauteren G,. Hepatitis C assays: operational characteristics. Geneva: World Health Organization; 2001.
37. Lin S, Arcangel P, Medina-Selby A, Coit D, Ng P, Nguyen S, McCoin C, Gyenes A, Hu C, Tandeske L, Phelps B, Chien D,. Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies. J Clin Microbiol 2005; 43: 3917-24.
38. Clinical Laboratory and Standards Institute. EP15-A2. User Verification of Performance for Precision and Trueness; Approved Guideline. 2nd ed. [cited 2012 Jun 6]. Available from: URL: http://www.clsi.org
39. Clinical Laboratory and Standards Institute. EP12-A2. User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline. 2nd ed. [cited 2012 Jun 6]. Available from: URL: http://www.clsi.org